Bioanalytical Techniques in Discrimination Between Therapeutic and Abusive Use of Drugs in Sport

References

• World Anti-Doping Agency . The World Anti-Doping Code. The Prohibited List. www.wada-ama.org/en/resources/science-medicine/prohibited-list.
   Google Scholar
• World Anti-Doping Agency . WADA Technical Document – TD2014DL. Decision limits for the confirmatory quantification of threshold substances. www.wada-ama.org/en/resources/science-medicine/td2014-dl.
   Google Scholar
• World Anti-Doping Agency . WADA Technical Document – TD2014MRPL. Minimum required performance levels for detection and identification of non-threshold substances. https://wada-main-prod.s3.amazonaws.com/resources/files/WADA-TD2014MRPL-v1-Minimum-Required-Performance-Levels-EN.pdf.
   Google Scholar
• Pluim BM , deHO, StaalJBet al. β2-Agonists and physical performance: a systematic review and meta-analysis of randomized controlled trials. Sports Med. 41 (1), 39–57 (2011).
   PubMed Web of Science ®Google Scholar
• Anderson SD , Sue-ChuM, PerryCPet al. Bronchial challenges in athletes applying to inhale a β2–agonist at the 2004 Summer Olympics. J. Allergy Clin. Immunol. 117 (4), 767–773 (2006).
   PubMed Web of Science ®Google Scholar
• Fitch KD . β2-Agonists at the Olympic Games. Clin. Rev. Allergy Immunol. 31 (2–3), 259–268 (2006).
   PubMed Web of Science ®Google Scholar
• Ventura R , SeguraJ, BergesRet al. Distinction of inhaled and oral salbutamol by urine analysis using conventional screening procedures for doping control. Ther. Drug Monit. 22 (3), 277–282 (2000).
   PubMed Web of Science ®Google Scholar
• Eibye K , ElersJ, PedersenLet al. Formoterol concentrations in blood and urine. the World Anti-Doping Agency 2012 regulations. Med. Sci. Sports Exerc. 45 (1), 16–22 (2013).
   PubMed Web of Science ®Google Scholar
• Ventura R , DamascenoLM, RamirezR, FarreM, BergesR, SeguraJ. Evaluation of the urinary threshold concentration of formoterol in sports drug testing. Drug Test. Anal. 5 (4), 266–269 (2013).
   PubMed Web of Science ®Google Scholar
• Pichon A , VenisseN, KrupkaE, Perault-PochatMC, DenjeanA. Urinary and blood concentrations of beta2-agonists in trained subjects: comparison between routes of use. Int. J. Sports Med. 27 (3), 187–192 (2006).
   PubMed Web of Science ®Google Scholar
• Schweizer C , SaugyM, KamberM. Doping test reveals high concentrations of salbutamol in a Swiss track and field athlete. Clin. J. Sport Med. 14 (5), 312–315 (2004).
   PubMed Web of Science ®Google Scholar
• Elers J , PedersenL, HenningeJ, HemmersbachP, DalhoffK, BackerV. The pharmacokinetic profile of inhaled and oral salbutamol in elite athletes with asthma and nonasthmatic subjects. Clin. J. Sport Med. 22 (2), 140–145 (2012).
   PubMed Web of Science ®Google Scholar
• Sporer BC , SheelAW, McKenzieDC. Dose response of inhaled salbutamol on exercise performance and urine concentrations. Med. Sci. Sports Exerc. 40 (1), 149–157 (2008).
   PubMed Web of Science ®Google Scholar
• Hostrup M , KalsenA, AuchenbergMet al. Urine concentrations of oral salbutamol in samples collected after intense exercise in endurance athletes. Drug Test. Anal. 6 (6), 528–532 (2014).
   PubMed Web of Science ®Google Scholar
• Damasceno L , VenturaR, OrtunoJ, SeguraJ. Derivatization procedures for the detection of beta(2)-agonists by gas chromatographic/mass spectrometric analysis. J. Mass Spectrom. 35 (11), 1285–1294 (2000).
   PubMed Web of Science ®Google Scholar
• Ventura R , DamascenoL, FarreM, CardosoJ, SeguraJ. Analytical methodology for the detection of beta(2)-agonists in urine by gas chromatography-mass spectrometry for application in doping control. Anal. Chim. Acta418 (1), 79–92 (2000).
   Web of Science ®Google Scholar
• Damasceno L , VenturaR, CardosoJ, SeguraJ. Diagnostic evidence for the presence of beta-agonists using two consecutive derivatization procedures and gas chromatography-mass spectrometric analysis. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 780 (1), 61–71 (2002).
   PubMed Web of Science ®Google Scholar
• Zhang J , XuY, DiX, WuM. Quantitation of salbutamol in human urine by liquid chromatography-electrospray ionization mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 831 (1–2), 328–332 (2006).
   PubMed Web of Science ®Google Scholar
• Ventura R , RamirezR, MonfortN, SeguraJ. Ultraperformance liquid chromatography tandem mass spectrometric method for direct quantification of salbutamol in urine samples in doping control. J. Pharm. Biomed. Anal. 50 (5), 886–890 (2009).
   PubMed Web of Science ®Google Scholar
• Lee KM , KimHJ, JeongESet al. Simple and accurate quantitative analysis of seven prohibited threshold substances in human urine by liquid chromatography/tandem mass spectrometry in doping control. Rapid Commun. Mass Spectrom. 25 (16), 2261–2267 (2011).
   PubMed Web of Science ®Google Scholar
• Mareck U , GuddatS, SchwenkeAet al. Determination of salbutamol and salbutamol glucuronide in human urine by means of liquid chromatography-tandem mass spectrometry. Drug Test. Anal. 3 (11–12), 820–827 (2011).
   PubMed Web of Science ®Google Scholar
• Thomas A , GeyerH, SchanzerWet al. Sensitive determination of prohibited drugs in dried blood spots (DBS) for doping controls by means of a benchtop quadrupole/Orbitrap mass spectrometer. Anal. Bioanal. Chem. 403 (5), 1279–1289 (2012).
   PubMed Web of Science ®Google Scholar
• Kiss A , LucioM, FildierA, BuissonC, Schmitt-KopplinP, Cren-OliveC. Doping control using high and ultra-high resolution mass spectrometry based non-targeted metabolomics-a case study of salbutamol and budesonide abuse. PLoS ONE8 (9), e74584 (2013).
   PubMed Web of Science ®Google Scholar
• Berges R , SeguraJ, VenturaRet al. Discrimination of prohibited oral use of salbutamol from authorized inhaled asthma treatment. Clin. Chem. 46 (9), 1365–1375 (2000).
   PubMed Web of Science ®Google Scholar
• Berges R , SeguraJ, de la TorreX, VenturaR. Analytical methodology for enantiomers of salbutamol in human urine for application in doping control. J. Chromatogr. B Biomed. Sci. Appl. 723 (1–2), 173–184 (1999).
   PubMedGoogle Scholar
• Deventer K , PozoOJ, DelbekeFT, Van EenooP. Quantitative detection of inhaled formoterol in human urine and relevance to doping control analysis. Drug Test. Anal. 4 (6), 449–454 (2012).
   PubMed Web of Science ®Google Scholar
• Mazzarino M , de la TorreX, FiaccoI, PompeiC, CalabreseF, BotreF. A simplified procedure for the analysis of formoterol in human urine by liquid chromatography-electrospray tandem mass spectrometry: application to the characterization of the metabolic profile and stability of formoterol in urine. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 931, 75–83 (2013).
   PubMed Web of Science ®Google Scholar
• Lee KM , KimHJ, SonJ, ParkJH, KwonOS, LeeJ. Simple quantitation of formoterol and 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid in human urine by liquid chromatography-tandem mass spectrometry in doping control. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 967, 8–12 (2014).
   PubMed Web of Science ®Google Scholar
• He G , LuJ, WangXet al. An improved liquid chromatography-tandem mass spectrometric method to quantify formoterol in human urine. J. Chromatogr. Sci. 52 (8), 848–851 (2014).
   PubMed Web of Science ®Google Scholar
• Deventer K , PozoOJ, DelbekeFT, Van EenooP. Quantitative detection of inhaled salmeterol in human urine and relevance to doping control analysis. Ther. Drug Monit. 33 (5), 627–631 (2011).
   PubMed Web of Science ®Google Scholar
• Van Thuyne W , Van EenooP, DelbekeFT. Nutritional supplements: prevalence of use and contamination with doping agents. Nutr. Res. Rev. 19 (1), 147–158 (2006).
   PubMed Web of Science ®Google Scholar
• Geyer H , ParrMK, KoehlerK, MareckU, SchanzerW, ThevisM. Nutritional supplements cross-contaminated and faked with doping substances. J. Mass Spectrom. 43 (7), 892–902 (2008).
   PubMed Web of Science ®Google Scholar
• Chan KH , PanRN, HsuMC, HsuKF. Urinary elimination of ephedrines following administration of the Traditional Chinese Medicine preparation Kakkon-to. J. Anal. Toxicol. 32 (9), 763–767 (2008).
   PubMed Web of Science ®Google Scholar
• Chan KH , HsuMC, ChenFA, HsuKF. Elimination of ephedrines in urine following administration of a Sho-seiryu-to preparation. J. Anal. Toxicol. 33 (3), 162–166 (2009).
   PubMed Web of Science ®Google Scholar
• Deventer K , Van EenooP, BaeleG, PozoOJ, Van ThuyneW, DelbekeFT. Interpretation of urinary concentrations of pseudoephedrine and its metabolite cathine in relation to doping control. Drug Test. Anal. 1 (5), 209–213 (2009).
   PubMed Web of Science ®Google Scholar
• Barroso O , GoudreaultD, Carbo BanusMLet al. Determination of urinary concentrations of pseudoephedrine and cathine after therapeutic administration of pseudoephedrine-containing medications to healthy subjects: implications for doping control analysis of these stimulants banned in sport. Drug Test. Anal. 4 (5), 320–329 (2012).
   PubMed Web of Science ®Google Scholar
• Chester N , MottramDR, ReillyT, PowellM. Elimination of ephedrines in urine following multiple dosing: the consequences for athletes, in relation to doping control. Br. J. Clin. Pharmacol. 57 (1), 62–67 (2004).
   PubMed Web of Science ®Google Scholar
• Strano-Rossi S , LeoneD, de la TorreX, BotreF. The relevance of the urinary concentration of ephedrines in anti-doping analysis: determination of pseudoephedrine, cathine, and ephedrine after administration of over-the-counter medicaments. Ther. Drug Monit. 31 (4), 520–526 (2009).
   PubMed Web of Science ®Google Scholar
• Delbeke FT , DebackereM. The influence of diuretics on the excretion and metabolism of doping agents: Part VI. Pseudoephedrine. Biopharm. Drug Dispos. 12 (1), 37–48 (1991).
   PubMed Web of Science ®Google Scholar
• Van Eenoo P , DelbekeFT, RoelsK, De BackerP. Simultaneous quantitation of ephedrines in urine by gas chromatography-nitrogen-phosphorus detection for doping control purposes. J. Chromatogr. B Biomed. Sci. Appl. 760 (2), 255–261 (2001).
   PubMedGoogle Scholar
• Jimenez C , VenturaR, WilliamsJ, SeguraJ, de la TorreR. Reference materials for analytical toxicology including doping control: freeze-dried urine samples. Analyst129 (5), 449–455 (2004).
   PubMed Web of Science ®Google Scholar
• Jimenez C , de la TorreR, VenturaM, SeguraJ, VenturaR. Stability studies of amphetamine and ephedrine derivatives in urine. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 843 (1), 84–93 (2006).
   PubMed Web of Science ®Google Scholar
• van der Merwe PJ , BrownLW, HendrikzSE. Simultaneous quantification of ephedrines in urine by high-performance liquid chromatography. J. Chromatogr. B Biomed. Appl. 661 (2), 357–361 (1994).
   PubMedGoogle Scholar
• Gmeiner G , GeisendorferT, KainzbauerJ, NikolajevicM, TauschH. Quantification of ephedrines in urine by column-switching high-performance liquid chromatography. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 768 (2), 215–221 (2002).
   PubMed Web of Science ®Google Scholar
• Spyridaki MH , TsitsimpikouCJ, SiskosPA, GeorgakopoulosCG. Determination of ephedrines in urine by gas chromatography-mass spectrometry. J. Chromatogr. B Biomed. Sci. Appl. 758 (2), 311–314 (2001).
   PubMedGoogle Scholar
• Spyridaki MH , KiousiP, VonapartiAet al. Doping control analysis in human urine by liquid chromatography-electrospray ionization ion trap mass spectrometry for the Olympic Games Athens 2004: determination of corticosteroids and quantification of ephedrines, salbutamol and morphine. Anal. Chim. Acta573–574, 242–249 (2006).
   PubMed Web of Science ®Google Scholar
• Deventer K , PozoOJ, Van EenooP, DelbekeFT. Development and validation of an LC–MS/MS method for the quantification of ephedrines in urine. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 877 (4), 369–374 (2009).
   PubMed Web of Science ®Google Scholar
• Badoud F , GrataE, PerrenoudL, SaugyM, RudazS, VeutheyJL. Fast analysis of doping agents in urine by ultra-high-pressure liquid chromatography-quadrupole time-of-flight mass spectrometry. II: confirmatory analysis. J. Chromatogr. A1217 (25), 4109–4119 (2010).
   PubMed Web of Science ®Google Scholar
• Gray N , MusengaA, CowanDA, PlumbR, SmithNW. A simple high pH liquid chromatography-tandem mass spectrometry method for basic compounds: application to ephedrines in doping control analysis. J. Chromatogr. A1218 (15), 2098–2105 (2011).
   PubMed Web of Science ®Google Scholar
• Heaton J , GrayN, CowanDA, PlumbRS, Legido-QuigleyC, SmithNW. Comparison of reversed-phase and hydrophilic interaction liquid chromatography for the separation of ephedrines. J. Chromatogr. A1228, 329–337 (2012).
   PubMed Web of Science ®Google Scholar
• Gray N , HeatonJ, MusengaA, CowanDA, PlumbRS, SmithNW. Comparison of reversed-phase and hydrophilic interaction liquid chromatography for the quantification of ephedrines using medium-resolution accurate mass spectrometry. J. Chromatogr. A1289, 37–46 (2013).
   PubMed Web of Science ®Google Scholar
• Monfort N , MartinezL, BergesR, SeguraJ, VenturaR. Screening method for stimulants in urine by UHPLC–MS/MS: identification of isomeric compounds. Drug Test. Anal. 7 (9), 819–830 (2015).
   PubMed Web of Science ®Google Scholar
• King JH , WeimerJR. Prednisone (meticorten) and prednisolone (meticortelone) in ophthamology; experimental and clinical studies. AMA. Arch. Ophthalmol. 54 (1), 46–54 (1955).
   PubMedGoogle Scholar
• Duclos M . Evidence on ergogenic action of glucocorticoids as a doping agent risk. Phys. Sportsmed. 38 (3), 121–127 (2010).
   PubMed Web of Science ®Google Scholar
• Simoes SMS , CalçadaM, HortaL, de la TorreX. Methylprednisolone detection in urine following local and oral administrations. In : Recent Advances in Doping Analysis (13). SchänzerW, GeyerH, GotzmannA, MareckU ( Eds). Sportverlag Strauss, Cologne, Germany, 411–414 (2005).
   Google Scholar
• Mazzarino M , BraganoMC, GarribbaF, RossiF, BotreF. The idea of a threshold value for synthetic glucocorticoids. urinary excretion studies following different routes of administration. In : Recent Advances in Doping Analysis (13). SchänzerW, GeyerH, GotzmannA, MareckU ( Eds). Sportverlag Strauss, Cologne, Germany, 465–468 (2005).
   Google Scholar
• Bredehöft M , ThevisM, SchänzerW. Excretion study. betamethasone–17,21–propionate ointment and possible metabolites in man analyzed with LC-ESI-MS/MS. In : Recent Advances in Doping Analysis (13). SchänzerW, GeyerH, GotzmannA, MareckU ( Eds). Sportverlag Strauss, Cologne, Germany, 415–418 (2005).
   Google Scholar
• Deventer K , MikulcikovaP, Van HoeckeH, Van EenooP, DelbekeFT. Detection of budesonide in human urine after inhalation by liquid chromatography-mass spectrometry. J. Pharm. Biomed. Anal. 42 (4), 474–479 (2006).
   PubMed Web of Science ®Google Scholar
• Panusa A , RegazzoniL, AldiniGet al. Urinary profile of methylprednisolone acetate metabolites in patients following intra-articular and intramuscular administration. Anal. Bioanal. Chem. 400 (1), 255–267 (2011).
   PubMed Web of Science ®Google Scholar
• Matabosch X , PozoOJ, Pérez-MañáCet al. Identification of budesonide metabolites in human urine after oral administration. Anal. Bioanal. Chem. 404 (2), 325–340 (2012).
   PubMed Web of Science ®Google Scholar
• Pozo OJ , MarcosJ, MataboschX, VenturaR, SeguraJ. Using complementary mass spectrometric approaches for the determination of methylprednisolone metabolites in human urine. Rapid Commun. Mass Spectrom. 26 (5), 541–553 (2012).
   PubMed Web of Science ®Google Scholar
• Matabosch X , PozoOJ, Pérez-MañáCet al. Discrimination of prohibited oral use from authorized inhaled treatment of budesonide in sports. Ther. Drug Monit. 35 (1), 118–128 (2013).
   PubMed Web of Science ®Google Scholar
• Matabosch X , PozoOJ, MonfortNet al. Urinary profile of methylprednisolone metabolites after oral and topical administrations. J. Steroid Biochem. Mol. Biol. 138 (C), 214–221 (2013).
   PubMedGoogle Scholar
• Matabosch X , PozoOJ, PapaseitEet al. Detection and characterization of triamcinolone acetonide metabolites in human urine by LC–MS/MS after intramuscular administration. Rapid Commun. Mass Spectrom. 28 (16), 1829–1839 (2014).
   PubMed Web of Science ®Google Scholar
• Matabosch X , MonfortN, PozoOet al. Urinary profile of betamethasone metabolites after different administration routes. Presented at : 32nd Cologne Workshop on Dope Analysis. Cologne, Germany, 30th March–4 April 2014.
   Google Scholar
• Matabosch X , PozoOJ, MonfortNet al. Detection and characterization of betamethasone metabolites in human urine by LC–MS/MS. Drug Test. Anal. 7 (8), 663–672 (2015).
   PubMed Web of Science ®Google Scholar
• Matabosch X , PozoOJ, Pérez-MañáCet al. Evaluation of the reporting level to detect triamcinolone acetonide misuse in sports. J. Steroid Biochem. Mol. Biol. 145, 94–102 (2015).
   PubMed Web of Science ®Google Scholar
• Matabosch X , PozoOJ, Perez-ManaC, PapaseitE, SeguraJ, VenturaR. Detection and characterization of prednisolone metabolites in human urine by LC–MS/MS. J. Mass Spectrom. 50 (3), 633–642 (2015).
   PubMed Web of Science ®Google Scholar
• Chang CW , HuangTY, TsengYC, Chang-ChienGP, LinSF, HsuMC. Positive doping results caused by the single-dose local injection of triamcinolone acetonide. Forensic Sci. Int. 244, 1–6 (2014).
   PubMed Web of Science ®Google Scholar
• World Anti-Doping Agency . 2013 Anti-Doping Testing Figures. www.wada-ama.org/en/resources/laboratories/2013-anti-doping-testing-figures-laboratory-report.
   Google Scholar
• Deventer K , DelbekeFT. Validation of a screening method for corticosteroids in doping analysis by liquid chromatography/tandem mass spectrometry. Rapid Commun. Mass Spectrom. 17 (18), 2107–2114 (2003).
   PubMed Web of Science ®Google Scholar
• Mazzarino M , TuriS, BotreF. A screening method for the detection of synthetic glucocorticosteroids in human urine by liquid chromatography-mass spectrometry based on class-characteristic fragmentation pathways. Anal. Bioanal. Chem. 390 (5), 1389–1402 (2008).
   PubMed Web of Science ®Google Scholar
• Gless KH , KleeHR, VecseiP, WeberM, HaackD, LichtwaldK. [Plasma concentration and systemic effect of betamethasone after intra-articular injection (author’s transl)]. Dtsch. Med. Wochenschr. 106 (22), 704–707 (1981).
   PubMed Web of Science ®Google Scholar
• Derendorf H , MollmannH, GrunerA, HaackD, GyselbyG. Pharmacokinetics and pharmacodynamics of glucocorticoid suspensions after intra-articular administration. Clin. Pharmacol. Ther. 39 (3), 313–317 (1986).
   PubMed Web of Science ®Google Scholar
• Mazzarino M , RossiF, GiacomelliL, BotreF. Effect of the systemic versus inhalatory administration of synthetic glucocorticoids on the urinary steroid profile as studied by gas chromatography-mass spectrometry. Anal. Chim. Acta559 (1), 30–36 (2006).
   Web of Science ®Google Scholar
• Fluri K , RivierL, Dienes-NagyAet al. Method for confirmation of synthetic corticosteroids in doping urine samples by liquid chromatography-electrospray ionisation mass spectrometry. J. Chromatogr. A926 (1), 87–95 (2001).
   PubMed Web of Science ®Google Scholar
• Segura J , VenturaR, JuradoC. Derivatization procedures for gas chromatographic-mass spectrometric determination of xenobiotics in biological samples, with special attention to drugs of abuse and doping agents. J. Chromatogr. B Biomed. Sci. Appl. 713 (1), 61–90 (1998).
   PubMed Web of Science ®Google Scholar
• Pozo OJ , VenturaR, MonfortN, SeguraJ, DelbekeFT. Evaluation of different scan methods for the urinary detection of corticosteroid metabolites by liquid chromatography tandem mass spectrometry. J. Mass Spectrom. 44 (6), 929–944 (2009).
   PubMed Web of Science ®Google Scholar
• Marcos J , RenauN, CasalsG, SeguraJ, VenturaR, PozoOJ. Investigation of endogenous corticosteroids profiles in human urine based on liquid chromatography tandem mass spectrometry. Anal. Chim. Acta812, 92–104 (2014).
   PubMed Web of Science ®Google Scholar
• Tudela E , MunozG, Munoz-GuerraJA. Matrix effect marker for multianalyte analysis by LC–MS/MS in biological samples. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 901, 98–106 (2012).
   PubMed Web of Science ®Google Scholar
• Savel’eva NB , BykovskaiaNI, DikunetsMA, BolotovSL, RodchenkovGM. [The use of the deuterated internal standard for morphine quantitation for the purpose of doping control by gas chromatography with mass-selective detection]. Sud. Med. Ekspert. 53 (3), 29–32 (2010).
   PubMedGoogle Scholar
• Solans A , de la TorreR, SeguraJ. Determination of morphine and codeine in urine by gas chromatography-mass spectrometry. J. Pharm. Biomed. Anal. 8 (8–12), 905–909 (1990).
   PubMed Web of Science ®Google Scholar
• Van Thuyne W , Van EenooP, DelbekeFT. Urinary concentrations of morphine after the administration of herbal teas containing Papaveris fructus in relation to doping analysis. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 785 (2), 245–251 (2003).
   PubMed Web of Science ®Google Scholar
• Gorgens C , GuddatS, OrloviusAKet al. “Dilute-and-inject” multi-target screening assay for highly polar doping agents using hydrophilic interaction liquid chromatography high resolution/high accuracy mass spectrometry for sports drug testing. Anal. Bioanal. Chem. 407 (18), 5365–5379 (2015).
   PubMed Web of Science ®Google Scholar